Please login to the form below

NPS

This page shows the latest NPS news and features for those working in and with pharma, biotech and healthcare.

The use of Fectroja in a range of infections is supported by data from three clinical studies, APEKS-cUTI, APEKS-NP, and CREDIBLE-CR.

Shionogi’s novel antibiotic trial data published in The Lancet

This included nosocomial pneumonia (NP), bloodstream infections (BSI), sepsis and complicated urinary tract infections (cUTI). ... The APEKS-NP study evaluated Fetcroja in severely ill patients with hospital-acquired, ventilator-associated or
Shionogi's Gram-negative antibiotic launches in the UK

The use of Fectroja in a range of infections is supported by data from three clinical studies, APEKS-cUTI, APEKS-NP, and CREDIBLE-CR.
Merck’s backing of NGM Bio yields NASH drug deal

The lead NASH candidate at that time was NP 201, but seems to have been leapfrogged by NGM313, now renamed MK-3655.
Redmile and Google help Evox raise £35.5m for exosome pipeline

Two proteins (NP-C1 and NP-C2) help control lipid transport within cells in patients with this disorder, with the majority (95%) of cases involving mutations in the NP-C1 gene.
Shire finally bags EU approval for rare disease drug Natpar

Natpar was one of the primary reasons Shire forked out $5.2bn to buy NPS Pharma in 2015 just before the FDA gave its go-ahead for the new therapy, which

More from news
Approximately 3 fully matching, plus 20 partially matching documents found.

The flexible salesforce

Interestingly, across all the countries mentioned above there has been no drop-off in the positive NPS for F2F, despite much lower activity and increased use of other channels. ... Germany also has a stable positive NPS at 35% and has seen F2F visits
Biotech profile: Tom Evans, CEO, Vaccitech.

As many of the safety and manufacturing issues surrounding our MVA-NP M1 vaccine are already de-risked, a positive efficacy readout in the challenge study should allow us to take
Digital mania - a question of value

So bad in fact, that the best Net Promoter Score (NPS) is a whopping -40% (minus!).
A rare talent

$6bn deal that was completed in January 2016. Before that the firm had a busy 2015, buying US rare disease-focused biotech NPS Pharma for $5.2bn and rare disease and
Deal Watch table for January 2015

NPS/Shire. NPS specialises in rare diseases including Gattex [teduglutide] for the treatment of short bowel syndrome.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Prevail Therapeutics adds to its board of directors

From 2008-2015 Nader was president and chief executive officer of NPS Pharma, until Shire acquired the company for $5.2bn. ... Before his time at NPS, Nader was a venture partner at Care Capital and he also previously served on the North America
CRISPR Therapeutics appoints Dr Tony Coles

He has also previously held executive and leadership positions at NPS Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb and Merck &Co.
Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance. US-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer. ... Fabbio has over 20 years of financial leadership experience in public and private

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Add my company

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

WHITE PAPER: Why do men die younger?: It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials: Here are some useful tips to help get your hands on authentically diverse stock photos....
Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...